(Q36103593)

12 August 2017

1 reference

title

Efficacy of AIDS vaccine strategies in nonhuman primates (English)

1 reference

12 August 2017

1

Klaus Uberla

1 reference

12 August 2017

publication date

21 April 2005

1 reference

Medical Microbiology and Immunology

12 August 2017

published in

1 reference

12 August 2017

volume

194

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

201-206

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-005-0238-5

12 August 2017

exact match

0 references

cites work

In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-005-0238-5

MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-005-0238-5

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-005-0238-5

Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-005-0238-5

Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-005-0238-5

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

12 December 2020

Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

1 reference

12 December 2020

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

12 December 2020

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses

1 reference

12 December 2020

A novel approach for producing lentiviruses that are limited to a single cycle of infection

1 reference

12 December 2020

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.

1 reference

12 December 2020

Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection

1 reference

12 December 2020

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

1 reference

12 December 2020

AIDS vaccines: back to 'plan A'.

1 reference

12 December 2020

Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya

1 reference

12 December 2020

Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines

1 reference

12 December 2020

Replication, Immunogenicity, and Protective Properties of Live-Attenuated Simian Immunodeficiency Viruses Expressing Interleukin-4 or Interferon-γ

1 reference

12 December 2020

Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239delta3 in adult and infant rhesus monkeys.

1 reference

12 December 2020

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

12 December 2020

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

12 December 2020

Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.

1 reference

12 December 2020

A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.

1 reference

12 December 2020

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids

1 reference

12 December 2020

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

1 reference

12 December 2020

Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T Lymphocytes

1 reference

12 December 2020

Whole inactivated SIV virion vaccines with functional envelope glycoproteins: safety, immunogenicity, and activity against intrarectal challenge

1 reference

12 December 2020

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

1 reference

12 December 2020

Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus

1 reference

12 December 2020

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

12 December 2020

The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response

1 reference

12 December 2020

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

12 December 2020

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

1 reference

12 December 2020

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen

1 reference

12 December 2020

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

12 December 2020

Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response

1 reference

12 December 2020

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

12 December 2020

A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H

1 reference

12 December 2020

Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles

1 reference

12 December 2020

Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes

1 reference

12 December 2020

Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.

1 reference

12 December 2020

Anti-cell antibody in macaques

1 reference

12 December 2020

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection

1 reference

12 December 2020

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

1 reference

12 December 2020

Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques

1 reference

12 December 2020

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

12 December 2020

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

12 December 2020

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

12 December 2020

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles

1 reference

12 December 2020

Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles

1 reference

12 December 2020

A conditionally replicating virus as a novel approach toward an HIV vaccine

1 reference

12 December 2020

Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection.

1 reference

12 December 2020

Defensins inhibit HIV replication in vitro

1 reference

12 December 2020

Clinical trials of HIV vaccines.

1 reference

12 December 2020

Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts

1 reference

12 December 2020

Vaccine development using the simian immunodeficiency virus model for AIDS.

1 reference

12 December 2020

HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood

1 reference

12 December 2020

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

12 December 2020

Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.

1 reference

12 December 2020

Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV

1 reference

12 December 2020

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

12 December 2020

Specific and non-specific immunity and protection of macaques against SIV infection

1 reference

12 December 2020

Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.

1 reference

12 December 2020

Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

1 reference

12 December 2020

A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

1 reference

12 December 2020

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

1 reference

12 December 2020

Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines

1 reference

12 December 2020

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine

1 reference

12 December 2020

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

10.1007/S00430-005-0238-5

Identifiers

DOI

1 reference

12 August 2017

1 reference